Find uplifting stories about heroes, innovations, and solutions
3408 results for "** fda approval"
The FDA just approved Optune Pax, a new treatment option for people battling locally advanced pancreatic cancer. This approval brings fresh hope to patients facing one of the most challenging cancer diagnoses.
The FDA just approved two new treatment combinations for cancer patients who've run out of options. These approvals bring fresh hope to people battling mantle cell lymphoma.
Millions of Alzheimer's patients who experience severe agitation now have a safer treatment option after the FDA approved Auvelity, a drug that works differently than risky antipsychotic medications. The approval gives hope to families struggling with one of the disease's most challenging symptoms.
The FDA just approved Denali Therapeutics' new medicine for Hunter syndrome, bringing fresh hope to families affected by this rare genetic disease. The approval comes as a welcome surprise after the agency recently toughened its standards for rare disease treatments.
After years without any approved therapies, adults living with chronic hepatitis delta virus now have hope with the FDA's approval of Hepcludex, the first treatment for one of the most severe forms of viral hepatitis. This breakthrough fills a critical gap for nearly 200,000 Americans who face rapid progression to serious liver complications.
People with a rare lung disease now have access to a more affordable treatment option after the FDA approved the first generic version of a life-changing medication. The new approval could help thousands of patients breathe easier, both physically and financially.
A new, stronger version of the popular weight loss medication Wegovy just got FDA approval, giving more Americans access to potentially more effective obesity treatment. The approval came through a new fast-track program designed to speed up medicines that address major health priorities.
A heart condition once called a death sentence now has multiple FDA-approved treatments that are keeping patients alive and out of hospitals. Cardiac amyloidosis patients are being diagnosed earlier and living longer thanks to breakthrough medications approved in the past year.
The FDA just approved a new treatment for adults with blastic plasmacytoid dendritic cell neoplasm, an extremely rare and aggressive blood cancer. This marks new hope for patients facing a disease with very few treatment options.
Families affected by Hunter syndrome now have hope as the FDA approves Avlayah, the first treatment designed to replace a missing enzyme that causes dangerous sugar buildup in the brain. This breakthrough marks a major victory for patients with this rare genetic disease.
Millions living with serious mental illness just got a new treatment option. The FDA approved Bysanti, offering hope for those managing bipolar 1 disorder and schizophrenia.
%3Amax_bytes(150000)%3Astrip_icc()%2F2208-05-074_cattle-0930040062ba48a497b4d462c206b168.jpg)
Ranchers and farmers now have better tools to protect their animals from a dangerous parasite that's been threatening U.S. livestock. The FDA just approved new sizes and expanded use of the only over-the-counter treatment available.
Americans will finally get access to a sunscreen ingredient Europe has used for decades, ending a 25-year gap in product innovation. The FDA's approval of bemotrizinol marks a major shift toward faster approval of safe, effective products.
The FDA just approved a new treatment option for people living with bipolar 1 disorder and schizophrenia. Bysanti offers fresh hope for millions managing these challenging mental health conditions.
A headset that uses gentle electrical pulses to treat depression just won FDA approval for home use. The device offers a medication-free option for millions struggling with mental health.
The FDA just approved teplizumab for children aged 8 and older with stage 3 type 1 diabetes, expanding treatment options for young patients. This marks an important step forward in managing a disease that affects over 300,000 American children.
Families dealing with Hunter syndrome just gained a powerful new treatment option after the FDA granted accelerated approval to Denali Therapeutics' groundbreaking drug. The decision marks a turning point for rare disease patients after a year of tougher regulatory outcomes.
Cancer patients gained several new FDA-approved tools this week, including tests to guide treatment decisions and drug combinations for hard-to-treat cancers. These advances offer fresh hope for more personalized, effective care.
A new combination therapy for aggressive prostate cancer just got FDA approval, along with two tests that help doctors match the right patients to this targeted treatment. This breakthrough could help up to 30% of men with advanced prostate cancer find a treatment plan designed specifically for their genes.
A groundbreaking depression treatment using psilocybin is showing promising results in clinical trials, potentially becoming the first psychedelic therapy approved by the FDA. Two major studies confirm the compound helps patients with severe depression find relief.
Showing 20 of 3408